The Interrelationships Between Lactose Intolerance and the Modern Dairy Industry: Global Perspectives in Evolutional and Historical Backgrounds
Total Page:16
File Type:pdf, Size:1020Kb
Load more
Recommended publications
-
Clinical Applications and Implications of Common and Founder Mutations in Indian Subpopulations
REVIEW OFFICIAL JOURNAL Clinical Applications and Implications of Common and Founder Mutations in Indian Subpopulations www.hgvs.org Arunkanth Ankala,1∗ † Parag M. Tamhankar,2 † C. Alexander Valencia,3,4 Krishna K. Rayam,5 Manisha M. Kumar,5 and Madhuri R. Hegde1 1Department of Human Genetics, Emory University School of Medicine, Atlanta, Georgia; 2ICMR Genetic Research Center, National Institute for Research in Reproductive Health, Mumbai, Maharashtra, India; 3Division of Human Genetics, Cincinnati Children’s Hospital Medical Center, Cincinnati, Ohio; 4Department of Pediatrics, University of Cincinnati Medical School, Cincinnati, Ohio; 5Department of Biosciences, CMR Institute of Management Studies, Bangalore, Karnataka, India Communicated by Arupa Ganguly Received 24 October 2013; accepted revised manuscript 16 September 2014. Published online 27 November 2014 in Wiley Online Library (www.wiley.com/humanmutation). DOI: 10.1002/humu.22704 that include a lack of widespread awareness about genetic disorders in the general population and the scarcity of specialized medical ABSTRACT: South Asian Indians represent a sixth of the world’s population and are a racially, geographically, and professionals and affordable genetic tests. Seeking a molecular di- genetically diverse people. Their unique anthropological agnosis and understanding the risk estimates are critical to making structure, prevailing caste system, and ancient religious sound reproductive choices, especially in families with an affected practices have all impacted the genetic composition of most individual. Adding to this adversity is the absence of a properly func- of the current-day Indian population. With the evolving tioning social health care system and insufficient encouragement socio-religious and economic activities of the subsects and of individual health insurance by the government. -
Incidence of Inborn Errors of Metabolism by Expanded Newborn
Original Article Journal of Inborn Errors of Metabolism & Screening 2016, Volume 4: 1–8 Incidence of Inborn Errors of Metabolism ª The Author(s) 2016 DOI: 10.1177/2326409816669027 by Expanded Newborn Screening iem.sagepub.com in a Mexican Hospital Consuelo Cantu´-Reyna, MD1,2, Luis Manuel Zepeda, MD1,2, Rene´ Montemayor, MD3, Santiago Benavides, MD3, Hector´ Javier Gonza´lez, MD3, Mercedes Va´zquez-Cantu´,BS1,4, and Hector´ Cruz-Camino, BS1,5 Abstract Newborn screening for the detection of inborn errors of metabolism (IEM), endocrinopathies, hemoglobinopathies, and other disorders is a public health initiative aimed at identifying specific diseases in a timely manner. Mexico initiated newborn screening in 1973, but the national incidence of this group of diseases is unknown or uncertain due to the lack of large sample sizes of expanded newborn screening (ENS) programs and lack of related publications. The incidence of a specific group of IEM, endocrinopathies, hemoglobinopathies, and other disorders in newborns was obtained from a Mexican hospital. These newborns were part of a comprehensive ENS program at Ginequito (a private hospital in Mexico), from January 2012 to August 2014. The retrospective study included the examination of 10 000 newborns’ results obtained from the ENS program (comprising the possible detection of more than 50 screened disorders). The findings were the following: 34 newborns were confirmed with an IEM, endocrinopathies, hemoglobinopathies, or other disorders and 68 were identified as carriers. Consequently, the estimated global incidence for those disorders was 3.4 in 1000 newborns; and the carrier prevalence was 6.8 in 1000. Moreover, a 0.04% false-positive rate was unveiled as soon as diagnostic testing revealed negative results. -
Hereditary Galactokinase Deficiency J
Arch Dis Child: first published as 10.1136/adc.46.248.465 on 1 August 1971. Downloaded from Alrchives of Disease in Childhood, 1971, 46, 465. Hereditary Galactokinase Deficiency J. G. H. COOK, N. A. DON, and TREVOR P. MANN From the Royal Alexandra Hospital for Sick Children, Brighton, Sussex Cook, J. G. H., Don, N. A., and Mann, T. P. (1971). Archives of Disease in Childhood, 46, 465. Hereditary galactokinase deficiency. A baby with galactokinase deficiency, a recessive inborn error of galactose metabolism, is des- cribed. The case is exceptional in that there was no evidence of gypsy blood in the family concerned. The investigation of neonatal hyperbilirubinaemia led to the discovery of galactosuria. As noted by others, the paucity of presenting features makes early diagnosis difficult, and detection by biochemical screening seems desirable. Cataract formation, of early onset, appears to be the only severe persisting complication and may be due to the biosynthesis and accumulation of galactitol in the lens. Ophthalmic surgeons need to be aware of this enzyme defect, because with early diagnosis and dietary treatment these lens changes should be reversible. Galactokinase catalyses the conversion of galac- and galactose diabetes had been made in this tose to galactose-l-phosphate, the first of three patient (Fanconi, 1933). In adulthood he was steps in the pathway by which galactose is converted found to have glycosuria as well as galactosuria, and copyright. to glucose (Fig.). an unexpectedly high level of urinary galactitol was detected. He was of average intelligence, and his handicaps, apart from poor vision, appeared to be (1) Galactose Gackinase Galactose-I-phosphate due to neurofibromatosis. -
Mild Galactosemia General Overview
Mild Galactosemia General Overview Q. What is mild galactosemia? A. Mild galactosemia affects the way the body processes the sugar galactose, a component of milk and dairy products. Children with mild galactosemia may have some difficulty processing galactose. As a result, galactose and other by-products can build up in the bloodstream. Q. Is there only one form of galactosemia? A. No, there are several forms. Mild galactosemia is a term used to describe the non-severe forms that usually do not require treatment. Q. How does the body normally process galactose? A. The body normally converts galactose into glucose, which is used for energy. This conversion is made possible by several enzymes. One of these, named galactose-1-phosphate uridyltransferase (GALT), is most often associated with mild galactosemia. Q. What happens to galactose in a child with mild galactosemia? A. In a child with mild galactosemia, the body has some difficulty converting galactose to glucose. This can result in some build-up of galactose and other by-products. Q. What are the effects of having mild galactosemia if it is not treated? A. Most infants who have mild galactosemia have no effects, even without treatment. Depending on the level of enzyme activity and milk intake, some infants may show signs of poor feeding and digestion. Q. What is the treatment for mild galactosemia? A. Mild galactosemia usually does not require treatment. However, some infants may benefit from reduced milk intake. If a child with mild galactosemia has difficulty tolerating breast milk or regular formula, soy based formula can be substituted. -
From “Viili” Towards “Termoviili”, a Novel Type of Fermented Milk
Avens Publishing Group Inviting Innovations Open Access Research Article J Food Processing & Beverages December 2013 Vol.:1, Issue:2 © All rights are reserved by Alatossava T et al. AvensJournal Publishing of Group InviFoodting Innovations Processing & From “Viili” Towards Beverages “Termoviili”, a Novel Type of Fermented Milk: Characterization Tapani Alatossava*, Ruojie Li and Patricia Munsch-Alatossava Department of Food and Environmental Sciences, University of of Growth Conditions and Factors Helsinki, Finland *Address for Correspondence Tapani Alatossava, Department of Food and Environmental Sciences, for a Co-culture of Lactobacillus P.O. Box 66, FI-00014 University of Helsinki, Helsinki, Finland, Tel: +358 9 191 58312; Fax: +358 9 191 58460; Email: [email protected] Submission: 11 November 2013 delbrueckii and Geotrichum Accepted: 12 December 2013 candidum Published: 18 December 2013 determinants for the production of fermented milk products with different tastes and flavors [1,2]. Fermented milks are beneficial to Keywords: Viili; yoghurt; Lactobacillus delbrueckii; Streptococcus thermophilus; Geotrichum candidum; formic acid; milk heat treatment human health, conditioning the intestine environment, lowering the blood pressure, and reducing the risks of bladder cancer and colon Abstract cancer [3-8]. Nowadays, the increasing consumption of fermented The traditional Northern fermented milk product “Viili” is based on milks offers a potential market for novel fermented milk products [9]. the use of a starter comprising both mesophilic lactic acid bacteria (LAB) and Geotricum candidum mold strains for milk fermentation at Globally among the commercial fermented milk products, yogurt 18 to 20°C for about 20 hours. The goal of the present study was to is the most popular product. -
Metabolic Liver Diseases Presenting As Acute Liver Failure in Children
R E V I E W A R T I C L E Metabolic Liver Diseases Presenting as Acute Liver Failure in Children SEEMA A LAM AND BIKRANT BIHARI LAL From Department of Pediatric Hepatology, Institute of Liver and Biliary Sciences, New Delhi, India. Correspondence to: Prof Seema Alam, Professor and Head, Department of Pediatric Hepatology, Institute of Liver and Biliary Sciences, New Delhi 110 070, India. [email protected] Context: Suspecting metabolic liver disease in an infant or young child with acute liver failure, and a protocol-based workup for diagnosis is the need of the hour. Evidence acquisition: Data over the last 15 years was searched through Pubmed using the keywords “Metabolic liver disease” and “Acute liver failure” with emphasis on Indian perspective. Those published in English language where full text was retrievable were included for this review. Results: Metabolic liver diseases account for 13-43% cases of acute liver failure in infants and young children. Etiology remains indeterminate in very few cases of liver failure in studies where metabolic liver diseases were recognized in large proportion. Galactosemia, tyrosinemia and mitochondrial disorders in young children and Wilson’s disease in older children are commonly implicated. A high index of suspicion for metabolic liver diseases should be kept when there is strong family history of consanguinity, recurrent abortions or sibling deaths; and history of recurrent diarrhea, vomiting, failure to thrive or developmental delay. Simple dietary modifications and/or specific management can be life-saving if instituted promptly. Conclusion: A high index of suspicion in presence of red flag symptoms and signs, and a protocol-based approach helps in timely diagnosis and prompt administration of life- saving therapy. -
Renewed Interest in Kefir, the Ancient Elixir of Longevity by Elinoar Shavit
M E D I C I N A L M U S H R O O M S Step 1. Place fresh kefir grains in a Step 2. Leave covered at room tempera- Step 3. Pour through a sieve to retain container of fresh milk. ture for 24 hours. grains. Step. 4. Place kefir grains into a con- Step 5. Pour kefir beverage into a glass. Step. 6. Chill for better flavor. tainer of fresh milk. Renewed Interest in Kefir, the Ancient Elixir of Longevity by Elinoar Shavit Kefir is an Old World food that has been attributed with excep- toms of diarrhea and chronic constipation, and lower the risk of tional health promoting and curative properties since the begin- colon cancer have been popular, along with the perception that ning of recorded history. It is a tangy, slightly fizzy (about 1% commercial yogurt and kefir are inferior to those fermented at alcohol), fermented milk beverage that looks a little like yogurt. home from natural starters. While anecdotal accounts to support It is rich in protein, calcium, vitamin B12, niacin, and folic acid.9 such claims abound, they are usually tossed aside as unsubstanti- Kefir and yogurt were popular at the turn of the 20th century, ated. What most people are not aware of is that these and other when scientists first studied claims about their contribution to claims about the health promoting and therapeutic properties of better health and increased longevity. The current rise in popu- fermented milk products have been validated by sound, evidence- larity of these fermented beverages around the world has sparked based, scientific research. -
Galactosemia, Or Galactose Diabetes
EDITORIALS over the years can recall certain patients with whom usually described as glycogen but might be galactogen. each of these measures seemed to be successful. How- In the eyes the lenses often show lamellar or nuclear ever, with none of them is relief obtained with any sig- cataracts. nificant degree of uniformity; and in a situation in The cause of these pathologic cellular changes is de- which various agents appear curative, it is doubtful if batable. Mason and Turner5 blamed the lowering of any is specific. The last word in the management of dia- blood glucose. But the absence of similar cellular damage betic neuropathy remains to be said and the present in disorders such as glycogen storage disease and hyper- state of the problem presents a real challenge to all in- insulinism, associated with low blood sugar, makes this 6 7 terested in diabetes. hypothesis doubtful. Several authors have suggested - ALEXANDER MARBLE, M.D. that the elevated blood galactose was a direct cause of Joslin Clinic, Boston the pathologic cellular abnormalities. Some investigat- ors8- 9 have produced lens opacities in rats by feeding large amounts of galactose. Dam's experiments10 with the GALACTOSEMIA, OR GALACTOSE feeding of galactose to chicks led him to the conclusion DIABETES that galactose damaged the central nervous system. Craig 11 Galactosemia, sometimes called galactose diabetes, is and Maddock have described the production of lens caused by an inborn error of metabolism that leads to opacities by high galactose diet in rats, associated with inability of the body tissues to utilize galactose. The failure of growth, increased urinary nitrogen and amino- aciduria, but without hepatocellular changes. -
Review Galactokinase: Structure, Function and Role in Type II
CMLS, Cell. Mol. Life Sci. 61 (2004) 2471–2484 1420-682X/04/202471-14 DOI 10.1007/s00018-004-4160-6 CMLS Cellular and Molecular Life Sciences © Birkhäuser Verlag, Basel, 2004 Review Galactokinase: structure, function and role in type II galactosemia H. M. Holden a,*, J. B. Thoden a, D. J. Timson b and R. J. Reece c,* a Department of Biochemistry, University of Wisconsin, Madison, Wisconsin 53706 (USA), Fax: +1 608 262 1319, e-mail: [email protected] b School of Biology and Biochemistry, Queen’s University Belfast, Medical Biology Centre, 97 Lisburn Road, Belfast BT9 7BL, (United Kingdom) c School of Biological Sciences, The University of Manchester, The Michael Smith Building, Oxford Road, Manchester M13 9PT, (United Kingdom), Fax: +44 161 275 5317, e-mail: [email protected] Received 13 April 2004; accepted 7 June 2004 Abstract. The conversion of beta-D-galactose to glucose unnatural sugar 1-phosphates. Additionally, galactoki- 1-phosphate is accomplished by the action of four en- nase-like molecules have been shown to act as sensors for zymes that constitute the Leloir pathway. Galactokinase the intracellular concentration of galactose and, under catalyzes the second step in this pathway, namely the con- suitable conditions, to function as transcriptional regula- version of alpha-D-galactose to galactose 1-phosphate. tors. This review focuses on the recent X-ray crystallo- The enzyme has attracted significant research attention graphic analyses of galactokinase and places the molecu- because of its important metabolic role, the fact that de- lar architecture of this protein in context with the exten- fects in the human enzyme can result in the diseased state sive biochemical data that have accumulated over the last referred to as galactosemia, and most recently for its uti- 40 years regarding this fascinating small molecule ki- lization via ‘directed evolution’ to create new natural and nase. -
“Viili” on the Adhesion of Probiotics and Pathogens to Intestinal Mucus
View metadata, citation and similar papers at core.ac.uk brought to you by CORE provided by Digital.CSIC J. Dairy Sci. 89:2355–2358 American Dairy Science Association, 2006. Short Communication: Effect of Exopolysaccharide Isolated from “Viili” on the Adhesion of Probiotics and Pathogens to Intestinal Mucus P. Ruas-Madiedo,*†1 M. Gueimonde,* C. G. de los Reyes-Gavila´n,† and S. Salminen* *Functional Foods Forum, University of Turku. Ita¨inen Pitka¨katu 4A, FIN 20014, Turku, Finland †Instituto de Productos La´cteos de Asturias (CSIC), Carretera de Infiesto s/n, 33300 Villaviciosa, Asturias, Spain ABSTRACT al., 1991) mediated by the stimulation of the mitogenic activity of B lymphocytes (Kitazawa et al., 1992). The strong ropy character of the Scandinavian fer- Probiotics have been defined as “viable microorgan- mented milk viili is conferred by the exopolysaccharides isms that exhibit a beneficial effect on the health of the (EPS) produced by lactococcal strains. These biopoly- host when they are ingested” (Salminen et al., 1998). mers can be responsible for some health benefits. We Strains of the genera Lactobacillus and Bifidobacterium have assessed the influence of the EPS fraction isolated are the most common probiotics used for human con- from commercial viili on the adhesion of some probiotics sumption; they can be present together with other lactic and pathogens to human intestinal mucus. Concentra- acid bacterial starters in commercial dairy products tions of viili EPS greater than 0.1 mg/mL promoted a (Playne et al., 2003; Talwalkar and Kailasapathy, 2004). decrease in adherence of Bifidobacterium lactis Bb12 One of the main criteria for the selection of probiotics is and Lactobacillus rhamnosus GG and this effect was the ability to adhere to the intestinal mucosa allowing dose-dependent. -
Association of Escherichia Coli Sepsis and Galactosemia in Neonates
J Am Board Fam Pract: first published as 10.3122/jabfm.5.1.89 on 1 January 1992. Downloaded from Association Of Escherichia coli Sepsis And Galactosemia In Neonates Phyllis Hoeflich Barr, D.O. Family physicians frequently care for neonates Follow-up care has been carried out in the who have jaundice and sepsis. There is a strong Department of Family Practice of the Naval association between serious infection and Hospital, Camp Pendleton, California, and the galactosemia in infants. A case is presented de Pediatric Metabolic Clinic of University of Cali scribing a neonate with jaundice and sepsis caused fornia, San Diego. Electrophoresis subsequently by Escherichia coli who was found to be galacto showed a low galactose-I-phosphate uridyl trans semic in the first week of life. The symptoms of ferase level (0.1 U/g hemoglobin; normal range galactosemia are discussed together with bio 18.5-28.5 U/g hemoglobin) as the cause of the chemical abnormalities leading to an increased galactosemia. Well-baby checkups at 2 and 4 frequency of infection and sepsis in these infants. months have shown her to be a vigorous infant in the 25th to 50th percentile for weight and Case Report length and the 50th percentile for circumference. A 20-year-old woman, gravida 2, para 1, abortus Bilateral small cataracts developed but are ex 0, gave birth to a 3800-g (8 lb, 3 oz) girl by pected to resolve on the lactose-free diet. The spontaneous vaginal delivery. Her prenatal course adequacy of the dietary therapy has been assessed was unremarkable. -
Inability to Convert Galactose to Glucose 2 Galactosemia
1 Galactosemia Inability to convert galactose to glucose 2 Galactosemia Inability to convert galactose to glucose 3 Galactosemia Inability to convert galactose to glucose Inheritance: ARabb. 4 Galactosemia Inability to convert galactose to glucose Inheritance: AR 5 Galactosemia Inability to convert galactose to glucose Inheritance: AR Results from a defect in one of the three# enzymes involved in galactose metabolism 6 Galactosemia Inability to convert galactose to glucose Inheritance: AR Results from a defect in one of the three enzymes involved in galactose metabolism 7 Galactosemia Inability to convert galactose to glucose Inheritance: AR Results from a defect in one of the three enzymes involved in galactose metabolism Classic galactosemia: most vs most vs Mostleast common and mostleast severe form 8 Galactosemia Inability to convert galactose to glucose Inheritance: AR Results from a defect in one of the three enzymes involved in galactose metabolism Classic galactosemia: Most common and most severe form 9 Galactosemia Inability to convert galactose to glucose Inheritance: AR Results from a defect in one of the three enzymes involved in galactose metabolism Classic galactosemia: Most common and most severe form Caused by defect in the uridyltransferasesomething-something-ase enzyme 10 Galactosemia Inability to convert galactose to glucose Inheritance: AR Results from a defect in one of the three enzymes involved in galactose metabolism Classic galactosemia: Most common and most severe form Caused